REG - Spire Healthcare Grp - Notice of Capital Markets Event

Spire HealthcareAnnouncement

21/03/2024 07:00

For best results when printing this announcement, please click on link below:
http://newsfile.refinitiv.com/getnewsfile/v1/story?guid=urn:newsml:reuters.com:20240321:nRSU6920Ha&default-theme=true

RNS Number : 6920H  Spire Healthcare Group PLC  21 March 2024

Spire Healthcare Group plc

 

('Spire Healthcare', 'the Company' or 'the Group')

 

Notice of Capital Markets Event

 

21 March 2024

 

Spire Healthcare Group plc (LSE: SPI), a leading UK independent healthcare
group in the UK, will be holding a Capital Markets Event for institutional
investors, sell-side analysts and lending banks at 10.00am on Wednesday 17
April 2024.

 

The event will be led by CEO Justin Ash and involve presentations by senior
executives covering the following topics:

 

·      Enhancing business performance

·      Introduction to Vita Health Group

·      Overview of Spire Occupational Health

 

The Capital Markets Event will be held at the offices of Instinctif Partners,
65 Gresham Street, London EC2V 7NQ, and is expected to last c.2.5 hours.
Refreshments will be available from 9.45am and a light lunch will be provided.

 

For those who cannot attend in person, the presentation will also be
accessible via live Zoom webcast.

 

Registration for the Capital Markets Event

 

·      If you wish to attend the presentation in-person, please contact
Instinctif Partners at spire@instinctif.com (mailto:spire@instinctif.com) .

·      Click the following link to register in advance for the live Zoom
webcast and to receive access details:
https://spirehealthcare.zoom.us/webinar/register/WN_oWnMSbVmQGisjIaTqS5MSg
(https://spirehealthcare.zoom.us/webinar/register/WN_oWnMSbVmQGisjIaTqS5MSg)

 

A recording of the webcast will be made available from 2.30 pm on 17 April on
the Spire Healthcare website, https://www.investors.spirehealthcare.com
(https://investors.spirehealthcare.com/)

 

No new material information will be disclosed during the event.

 

- Ends -

 

For further information please contact:

 

 Spire Healthcare                                  +44 (0)7974 982 512

 Angus Prentice - Director of Investor Relations

 Instinctif Partners

 Damian Reece                                      +44 (0)7931 598 593

 Guy Scarborough                                   +44 (0)7917 178 920

 Jeremy Durrant                                    +44 (0)7792 918 648

 

Registered Office and Head Office:

Spire Healthcare Group plc

3 Dorset Rise

London

EC4Y 8EN

Registered number 09084066

 

About Spire Healthcare

Spire Healthcare (http://www.spirehealthcare.com) is a leading independent
healthcare group in the United Kingdom, with 39 hospitals and over 50 clinics,
medical centres and consulting rooms across England, Wales and Scotland. It
operates a network of private GPs and provides occupational health services to
over 800 corporate clients.

 

Working in partnership with over 8,600 experienced consultants, Spire
Healthcare delivered tailored, personalised care to over one million
inpatients, outpatients and daycase patients, and occupational health
programme clients, in 2023, and is the leading private provider, by volume, of
knee
(https://www.spirehealthcare.com/treatments/bones-and-joints/knee-replacement/)
and hip
(https://www.spirehealthcare.com/treatments/bones-and-joints/hip-replacement-surgery/)
operations in the United Kingdom. It also delivers a range of private and NHS
mental health, musculoskeletal and dermatological services.

 

Spire Healthcare's well-located and scalable hospitals have delivered
successful and award-winning outcomes, positioning the group well with
patients, consultants, the NHS, GPs and Private Medical Insurance ('PMI')
providers. 98% of Spire Healthcare's inspected locations are rated 'Good,'
'Outstanding' or the equivalent by health inspectors in England, Wales and
Scotland.

 

Spire Healthcare is listed on the London Stock Exchange and is a member of the
FTSE 250.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact
rns@lseg.com (mailto:rns@lseg.com)
 or visit
www.rns.com (http://www.rns.com/)
.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our
Privacy Policy (https://www.lseg.com/privacy-and-cookie-policy)
.   END  MSCURARRSUUOUUR